SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001517022-23-000011
Filing Date
2023-06-07
Accepted
2023-06-07 07:31:43
Documents
27
Period of Report
2023-06-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akba-20230607.htm   iXBRL 8-K 42839
2 EX-99.1 exhibit991-jefferies_ake.htm EX-99.1 16060
7 exhibit991-jefferies_ake001.jpg GRAPHIC 49514
8 exhibit991-jefferies_ake002.jpg GRAPHIC 169378
9 exhibit991-jefferies_ake003.jpg GRAPHIC 47872
10 exhibit991-jefferies_ake004.jpg GRAPHIC 111510
11 exhibit991-jefferies_ake005.jpg GRAPHIC 115229
12 GRAPHIC exhibit991-jefferies_ake006.jpg GRAPHIC 57709
13 exhibit991-jefferies_ake007.jpg GRAPHIC 118964
14 exhibit991-jefferies_ake008.jpg GRAPHIC 106616
15 exhibit991-jefferies_ake009.jpg GRAPHIC 89522
16 exhibit991-jefferies_ake010.jpg GRAPHIC 114045
17 exhibit991-jefferies_ake011.jpg GRAPHIC 84762
18 exhibit991-jefferies_ake012.jpg GRAPHIC 84407
19 exhibit991-jefferies_ake013.jpg GRAPHIC 32770
  Complete submission text file 0001517022-23-000011.txt   1849600

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20230607.xsd EX-101.SCH 2258
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20230607_def.xml EX-101.DEF 3783
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20230607_lab.xml EX-101.LAB 27680
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20230607_pre.xml EX-101.PRE 14595
21 EXTRACTED XBRL INSTANCE DOCUMENT akba-20230607_htm.xml XML 11395
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 23997662
SIC: 2834 Pharmaceutical Preparations